NEUVITAE
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Apr 2019)
What this means for you
This application is over — abandoned 22 Apr 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87535473
- Mark type
- Stylized text
- Filed
- 20 Jul 2017
- Published for opposition
- 23 Jan 2018
- Abandoned
- 22 Apr 2019
- Attorney of record
- Roberta Jacobs-Meadway
Goods and services
- Class 009 — Scientific and electric apparatus: downloadable electronic newsletters and bulletins published periodically related to medical devices
- Class 010 — Medical apparatus: implantable spinal scaffolds
- Class 016 — Paper goods and printed matter: paper and printed material products, namely, newsletters and bulletins published periodically related to medical devices
- Class 035 — Advertising and business services: promoting the interests of spinal scaffold implant patients
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information to spinal scaffold implant patients, to persons caring for such patients, and to health providers
Owner
- Invivo Therapeutics Corporation, Cambridge, MA, US
- Invivo Therapeutics Corporation, Cambridge, MA, US
Prosecution history
- 22 Apr 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Apr 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Sept 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2018 — SOU EXTENSION 1 GRANTED
- 20 Sept 2018 — SOU EXTENSION 1 FILED
- 20 Sept 2018 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jan 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jan 2018 — PUBLISHED FOR OPPOSITION
- 03 Jan 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Dec 2017 — ASSIGNED TO LIE
- 29 Nov 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Nov 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Nov 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED